These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

260 related items for PubMed ID: 6133901

  • 21. The pharmacokinetics of daptomycin in moderately obese, morbidly obese, and matched nonobese subjects.
    Dvorchik BH, Damphousse D.
    J Clin Pharmacol; 2005 Jan; 45(1):48-56. PubMed ID: 15601805
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. NTP Toxicology and Carcinogenesis Studies of Oxazepam (CAS No. 604-75-1) in Swiss-Webster and B6C3F1 Mice (Feed Studies).
    National Toxicology Program .
    Natl Toxicol Program Tech Rep Ser; 1993 Aug; 443():1-321. PubMed ID: 12595920
    [Abstract] [Full Text] [Related]

  • 25. Clinical pharmacokinetics of lorazepam: a review.
    Kyriakopoulos AA, Greenblatt DJ, Shader RI.
    J Clin Psychiatry; 1978 Oct; 39(10 Pt 2):16-23. PubMed ID: 30762
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. The pharmacokinetics of dexfenfluramine in obese and non-obese subjects.
    Cheymol G, Weissenburger J, Poirier JM, Gellee C.
    Br J Clin Pharmacol; 1995 Jun; 39(6):684-7. PubMed ID: 7654489
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Obesity as a risk factor in drug-induced organ injury: increased liver and kidney damage by acetaminophen in the obese overfed rat.
    Corcoran GB, Wong BK.
    J Pharmacol Exp Ther; 1987 Jun; 241(3):921-7. PubMed ID: 3598908
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Clinical pharmacokinetics of lorazepam. III. Intravenous injection. Preliminary results.
    Greenblatt DJ, Comer WH, Elliott HW, Shader RI, Knowles JA, Ruelius HW.
    J Clin Pharmacol; 1977 Jun; 17(8-9):490-4. PubMed ID: 19508
    [Abstract] [Full Text] [Related]

  • 35. Single dose oxazepam has no effect on acetaminophen clearance or metabolism.
    Sonne J, Poulsen HE, Andreasen PB.
    Eur J Clin Pharmacol; 1986 Jun; 30(1):127-9. PubMed ID: 3709627
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Verapamil pharmacodynamics and disposition in obese hypertensive patients.
    Abernethy DR, Schwartz JB.
    J Cardiovasc Pharmacol; 1988 Feb; 11(2):209-15. PubMed ID: 2452316
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Benzodiazepine concentrations in brain directly reflect receptor occupancy: studies of diazepam, lorazepam, and oxazepam.
    Greenblatt DJ, Sethy VH.
    Psychopharmacology (Berl); 1990 Feb; 102(3):373-8. PubMed ID: 1979181
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.